Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

NicOx designs improved antiinflammatory, analgesic and antithrombotic compounds

Oct. 19, 2000

NCX-4016 superior to aspirin in reducing myocardial infarct size in animal model

Oct. 19, 2000

Nonpeptide Y1 antagonist H-409/22 examined for in vivo effects on vascular responses

Oct. 19, 2000

AstraZeneca licenses antiarrhythmic drug candidate from Nortran

Oct. 19, 2000

Nortran's new ion channel blockers useful as antiarrhythmics

Oct. 18, 2000

Esperion acquires biotechnology company; LUV program proceeds ahead of schedule

Oct. 18, 2000

Potent Na+/H+ exchange inhibitor TY-12533 displays excellent cardioprotective profile in vivo

Oct. 18, 2000

Preliminary human safety and PK/PD findings reported for Z-13752A

Oct. 18, 2000

Second gene therapy product from Collateral advances to clinical testing

Oct. 16, 2000

Roche presents recently identified endothelin receptor antagonists

Oct. 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...